Cargando…
Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406710/ https://www.ncbi.nlm.nih.gov/pubmed/37354349 http://dx.doi.org/10.1007/s10198-023-01607-5 |
| _version_ | 1785085804585943040 |
|---|---|
| author | Gandjour, Afschin |
| author_facet | Gandjour, Afschin |
| author_sort | Gandjour, Afschin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10406710 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104067102023-08-09 Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment Gandjour, Afschin Eur J Health Econ Commentary Springer Berlin Heidelberg 2023-06-24 2023 /pmc/articles/PMC10406710/ /pubmed/37354349 http://dx.doi.org/10.1007/s10198-023-01607-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Commentary Gandjour, Afschin Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment |
| title | Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment |
| title_full | Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment |
| title_fullStr | Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment |
| title_full_unstemmed | Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment |
| title_short | Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment |
| title_sort | impact of the introduction of the amnog law on launch delays of new drugs in germany: a comment |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406710/ https://www.ncbi.nlm.nih.gov/pubmed/37354349 http://dx.doi.org/10.1007/s10198-023-01607-5 |
| work_keys_str_mv | AT gandjourafschin impactoftheintroductionoftheamnoglawonlaunchdelaysofnewdrugsingermanyacomment |